Company / Total Assets
Rapport Therapeutics, Inc. Total Assets History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$314.9M
FY2024
5-year range
$155.4M / $314.9M
FY2023-FY2024
Trend
+102.6%
vs FY2023
Sector context
#180 of 214
Health Care
What the data says
Rapport Therapeutics, Inc.'s total assets of $315M is lower than 84% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
$315M in FY2024.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 214This company $314.9M Sector average $7.5B
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2024, total assets increased 102.6% year-over-year.
- Ranks #180 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 13.36 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $314.9M | +102.6% |
| FY2023 | $155.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026